Basics |
Company: |
KalVista Pharmaceuticals, Inc. |
IPO Date: |
April 9, 2015 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$495.66M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.40 | 2.97%
|
Avg Daily Range (30 D): |
$0.24 | 2.65%
|
Avg Daily Range (90 D): |
$0.28 | 2.89%
|
Institutional Daily Volume |
Avg Daily Volume: |
.2M |
Avg Daily Volume (30 D): |
.26M |
Avg Daily Volume (90 D): |
.28M |
Trade Size |
Avg Trade Size (Sh.): |
84 |
Avg Trade Size (Sh.) (30 D): |
58 |
Avg Trade Size (Sh.) (90 D): |
63 |
Institutional Trades |
Total Inst.Trades: |
631 |
Avg Inst. Trade: |
$1.5M |
Avg Inst. Trade (30 D): |
$.91M |
Avg Inst. Trade (90 D): |
$1.29M |
Avg Inst. Trade Volume: |
.1M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.48M |
Avg Closing Trade (30 D): |
$.56M |
Avg Closing Trade (90 D): |
$1.08M |
Avg Closing Volume: |
91.96K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.91
|
$-.87
|
$-1.07
|
Diluted EPS
|
$-.91
|
$-.87
|
$-1.07
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -42.27M
|
$ -40.44M
|
$ -44.65M
|
Operating Income / Loss
|
$ -45.81M
|
$ -44.22M
|
$ -48.46M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 9.33M
|
$ -.06M
|
$ 8.81M
|
PE Ratio
|
|
|
|
Splits |
Nov 22, 2016:
14:1
|
|